Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-24-000102
Filing Date
2024-11-08
Accepted
2024-11-08 08:01:37
Documents
104
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20240930.htm   iXBRL 10-Q 2065559
2 EX-10.4 a104anipharmaceuticalsinca.htm EX-10.4 21073
3 EX-10.5 a105anipharmaceuticalsinca.htm EX-10.5 77571
4 EX-31.1 anip-20240930x10qxexx311.htm EX-31.1 10314
5 EX-31.2 anip-20240930x10qxexx312.htm EX-31.2 9843
6 EX-32.1 anip-20240930x10qxexx321.htm EX-32.1 7028
  Complete submission text file 0001023024-24-000102.txt   12119660

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anip-20240930.xsd EX-101.SCH 80041
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anip-20240930_cal.xml EX-101.CAL 112495
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anip-20240930_def.xml EX-101.DEF 524503
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anip-20240930_lab.xml EX-101.LAB 957580
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anip-20240930_pre.xml EX-101.PRE 756478
107 EXTRACTED XBRL INSTANCE DOCUMENT anip-20240930_htm.xml XML 1727747
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 241438051
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)